Mandate

Vinge advises EQT VII in its acquisition of Eton Group AB

December 30, 2015

Vinge advises EQT VII in its acquisition of Eton Group AB and its subsidiaries in Sweden, the US, Canada and the UK (together “Eton”) from Litorina IV and a number of minority shareholders. Founded in Gånghester, Sweden, in 1928, Eton is today a global premium men’s shirts brand, offering shirts and directly linked accessories. Eton primarily sells through department stores, complemented with five own brand stores and its own online store. Eton is still headquartered in Gånghester and has approximately 155 employees across the world. The transaction is conditional upon approval from competition authorities and is expected to close in early 2016.

Vinge’s team consists of partners Christina Kokko and Peter Sundgren together with associates Sofie Bjärtun and Adriana Berglund (both M&A), Karin Virding (IP), Parul Sharma and Linn Gustavsson (both CSR), Karin Isacsson (employment), Nicklas Thorgezon (IT), Jasmin Draszka-Ali, Ulrich Ziche and Maria Dahlin (agreements), Adam Sandberg (financing), Anna Lonergran (real property), Helena Höök (competition law) as well as project assistant Josefin Backlund. Partner Marcus Glader and associates Grant McKelvey and Johanna Bjurling advice in relation to merger filing.

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026